Literature DB >> 25849491

Design and synthesis of fluorinated dendrimers for sensitive (19)F MRI.

Weijiang Yu1, Yuqi Yang2, Shaowei Bo3, Yu Li1, Shizhen Chen2, Zhigang Yang1, Xing Zheng3, Zhong-Xing Jiang1,3, Xin Zhou2.   

Abstract

To achieve high sensitivity for (19)F MRI, a class of novel dendritic molecules with multiple pseudosymmetrical fluorines was designed and efficiently synthesized. Through iterative bromination and Williamson ether synthesis under mild conditions, a fluorinated dendrimer with 540 pseudosymmetrical fluorines was conveniently prepared without performing the group protection in a convergent way. The dendrimer is characterized by a strong (19)F NMR peak and short relaxation times. Eventually, an appreciably enhanced (19)F MRI at an extremely low concentration (18.5 μM) was achieved, which demonstrated the potential utility of such dendritic molecules in highly sensitive (19)F MRI.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25849491     DOI: 10.1021/acs.joc.5b00294

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  10 in total

1.  Synthesis of Intrinsically Disordered Fluorinated Peptides for Modular Design of High-Signal 19 F MRI Agents.

Authors:  Steven E Kirberger; Sofia D Maltseva; Joseph C Manulik; Samuel A Einstein; Bradley P Weegman; Michael Garwood; William C K Pomerantz
Journal:  Angew Chem Int Ed Engl       Date:  2017-05-04       Impact factor: 15.336

Review 2.  Nanotechnology as a Versatile Tool for 19F-MRI Agent's Formulation: A Glimpse into the Use of Perfluorinated and Fluorinated Compounds in Nanoparticles.

Authors:  Joice Maria Joseph; Maria Rosa Gigliobianco; Bita Mahdavi Firouzabadi; Roberta Censi; Piera Di Martino
Journal:  Pharmaceutics       Date:  2022-02-09       Impact factor: 6.321

3.  A Multifunctional Contrast Agent for 19F-Based Magnetic Resonance Imaging.

Authors:  Liang Du; Shannon Helsper; Neda Arabzadeh Nosratabad; Wentao Wang; Debra Ann Fadool; Catherine Amiens; Samuel Grant; Hedi Mattoussi
Journal:  Bioconjug Chem       Date:  2022-04-21       Impact factor: 6.069

Review 4.  Application of Dendrimers in Anticancer Diagnostics and Therapy.

Authors:  Zuzanna Bober; Dorota Bartusik-Aebisher; David Aebisher
Journal:  Molecules       Date:  2022-05-18       Impact factor: 4.927

5.  Design, synthesis and evaluation of novel 19F magnetic resonance sensitive protein tyrosine phosphatase inhibitors.

Authors:  Yu Li; Guiquan Xia; Qi Guo; Li Wu; Shizhen Chen; Zhigang Yang; Wei Wang; Zhong-Yin Zhang; Xin Zhou; Zhong-Xing Jiang
Journal:  Medchemcomm       Date:  2016-06-20       Impact factor: 3.597

Review 6.  Two decades of dendrimers as versatile MRI agents: a tale with and without metals.

Authors:  Michael T McMahon; Jeff W M Bulte
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-09-11

Review 7.  19 F MRI Nanotheranostics for Cancer Management: Progress and Prospects.

Authors:  Yanan Li; Jing Cui; Chenlong Li; Huimin Zhou; Jun Chang; Omer Aras; Feifei An
Journal:  ChemMedChem       Date:  2022-01-12       Impact factor: 3.540

Review 8.  Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.

Authors:  Jörgen Elgqvist
Journal:  Int J Mol Sci       Date:  2017-05-20       Impact factor: 5.923

9.  Preliminary 19F-MRS Study of Tumor Cell Proliferation with 3'-deoxy-3'-fluorothymidine and Its Metabolite (FLT-MP).

Authors:  In Ok Ko; Ki-Hye Jung; Mi Hyun Kim; Kyeung Jun Kang; Kyo Chul Lee; Kyeong Min Kim; Insup Noh; Yong Jin Lee; Sang Moo Lim; Jung Young Kim; Ji-Ae Park
Journal:  Contrast Media Mol Imaging       Date:  2017-09-26       Impact factor: 3.161

10.  Accelerated 19F·MRI Detection of Matrix Metalloproteinase-2/-9 through Responsive Deactivation of Paramagnetic Relaxation Enhancement.

Authors:  Henryk M Faas; James L Krupa; Alexander J Taylor; Francesco Zamberlan; Christopher J Philp; Huw E L Williams; Simon R Johnson; Galina E Pavlovskaya; Neil R Thomas; Thomas Meersmann
Journal:  Contrast Media Mol Imaging       Date:  2019-02-28       Impact factor: 3.161

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.